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ABSTRACT 
The study objectives were: 1) to characterise the development of immunocompetence in beef 
suckler calves from birth to three months of age, and 2) to trace glycoprotein E (gE)-negative 
bovine herpesvirus type 1 (BoHV-1) antibodies from dam to calf and subsequent vaccination 
against pneumonia. Thirty multiparous beef suckler, spring-calving cows, consisting of two 
genotypes were involved; Limousin×Friesian (LF) and Charolais×Limousin (CL).  Cows 
were immunised against the inactivated antigen strain of BoHV-1 (gE- (IBR marker vaccine) 
at day -84 and received a booster at day -56 relative to the expected calving date (d 0). Calves 
were immunized at 14 and 42 days of age against PI-3 virus, BRSV and Mannheimia 
(Pasteurella) haemolytica serotype A1 using a commercial vaccine administered 
subcutaneously. Additionally, calves were immunized against BoHV-1 at 42 days of age, 
using 1 dose of a live commercial vaccine administered intranasally.  Blood samples were 
collected from all calves (n=30) via jugular venipuncture at birth, prior to colostrum feeding 
(0 h), at 12 hour (h), 24 h, 72 h and 168 h after the initial feeding of colostrum, and at d 7, 14, 
28, 42, 56 and 84 post birth. The mean ratio of gE negative antibodies circulating in the blood 
of LF and CL dams pre-partum scored negative to gE ab (S/N = > 0.70). Antibody levels of 
BoHV-1 (wt) peaked at 12 hours post-birth in calves and declined thereafter, as the maternal 
antibodies decayed. There was no difference in BoHV-1 and BRSV antibody levels in calves 
post vaccination.  
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1. Introduction 
The positive association between passive immune status, neonatal health and mortality in 
calves is well established (Earley et al., 2000; Waldner and Rosengren, 2009; Stelwagen et 
al., 2009; Furman-Fratczak et al., 2011; Niewiesk, 2014; Raboisson et al., 2016).  In the 
suckled beef calf, there are large differences in passive immunity between cow breed types 
(McGee et al., 2005a, 2005b; Murphy et al., 2005). Peak incidence of bovine respiratory 
disease (BRD) occurs in young calves, less than 6 months of age, often in the face of pre-
existing maternally derived antibodies (MDA) (Patel and Didlick, 2004). Infectious causes of 
BRD include viral (bovine herpesvirus-1 virus ((BoHV-1/infectious bovine rhinotracheitis 
(IBR) virus), bovine coronavirus (BoCV), bovine respiratory syncytial virus (BRSV), bovine 
viral diarrhoea virus (BVDV), parainfluenza-3 virus (PI3V), bovine adenoviruses, bovine 
enterovirus-1, -2 and -3), bacteriological, (Mannheimia haemolytica, Pasteurella multocida, 
Histophilus somni)  and mycoplasmal agents (Mycoplasma bovis), many of which are 
indigenous residents of the bovine respiratory tract (Taylor et al., 2010a; 2010b; 2015; 
Brooks et al., 2011).  
Marker vaccines are commercially available, inactivated or live-attenuated (Kaashoek et al. 
1994; Kaashoek et al., 1995) and for BoHV-1 the gene coding for the unnecessary 
glycoprotein E (gE) has been deleted. This allows for serological differentiation between 
artificial vaccination and cattle that were naturally infected (Van Oirschot et al. 1997). This is 
a useful method to detect infected animals and eliminate them from the herd to prevent the 
possibility of reactivation of latent virus (Ackermann et al. 1990; Kaashoek et al., 1995). 
Many vaccine protocols have been developed to vaccinate young calves at frequencies as 
often as weekly during the first and second months of age. Finding any experimental studies 
that support this timing is difficult as limited research is available to indicate the true 
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effectiveness of vaccine timing or ideal protocols for use in young calves (Chase et al., 2008). 
Viruses including BoHV-1, BRSV and PI-3V have an important role in BRD, not only in the 
pathogenesis of the disease but also in the development of immunosuppression (Murray et 
al., 2017).  Furthermore, calf immunisation against BRD causing pathogens may be adversely 
affected by interference from maternally derived antibodies (Chase et al., 2008), neonatal 
hormonal factors (Morein et al., 2002) or unfavourable environmental conditions. Infectious 
bovine rhinotracheitis (IBR) is a highly contagious respiratory disease that is caused by 
bovine herpesvirus 1 (BoHV-1), in the subfamily Alphaherpesvirinae of the Herpesviridae 
family.  Vaccines currently used in BoHV-1 control programs in certain EU countries utilize 
highly attenuated BoHV-1 strains marked by a deletion of the glcoprotein E 9gE gene 
(Muylkens et al., 2006) also known as the Glycoprotein E (gE)-deleted marker vaccine.  
Glycoprotein E is the established virulence factor of all known members of the subfamily 
Alphaherpesvirinae (van Engelenburg et al., 1994; Rebordosa et al., 1996). 
The objectives of this study were 1), to characterise the development of immunocompetence 
in beef suckler calves from birth to three months of age, and 2), to trace glycoprotein E (gE)-
negative BoHV-1 antibodies from vaccinated dams to calf sera and investigate how passive 
transfer of immunity affects response in calves to live BoHV-1 vaccine at 14 days of age, and 
to Bovilis®Bovipast RSP vaccine at 14 and 42 days of age. 
 
2. Materials and Methods 
 
2.1 Animal ethics approval  
All animal procedures performed in this study were conducted under experimental licence 
from the health products regulation authority (HPRA), Dublin, Ireland (individual 
authorisation number, AE 19132/I073; project licence number, AE 19132/P006).  
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2.2  Study area 
This study was conducted on the beef suckler herd, at Teagasc Grange, located in Co. Meath, 
Ireland (latitude 53.52187, longitude -6.65247).  
2.3 Animals, feeding and general management 
The study consisted of thirty multiparous (MP) beef suckler, spring-calving cows. Two cow 
breeds were examined: Limousin × Friesian (LF) (n = 17) and Charolais × Limousin (CL) (n 
= 13). Mean parity (SD) for LF and CL cows was 5.5 (0.94) and 5.3 (1.03), respectively. The 
mean calving date was 28th February 2015 (26th January to 27th April). The cows were bred 
using an Aberdeen Angus (AA) and Charolais (CH) sires (natural mating). The beef suckler 
cows were housed in pens in a concrete slatted-floor shed in November 2014 and offered 
second-cut grass silage ad libitum (in vitro dry matter digestibility (DMD) (615 g/kg). All 
cows received a mineral and vitamin supplement daily (60g/head) while housed. The cows 
that calved prior to April were turned out to pasture in early April. Cows that calved from 
early April onwards were turned out within 2 to 7 days of calving. Prior to parturition 
(approximately 1 to 7 days) the cows were moved from the slatted-floor shed to straw bedded 
calving pens. Births were supervised by farm personnel to ensure that calves did not suckle 
the cow prior to implementing the experimental protocol for collection of the first blood 
sample from the calf. Immediately post-partum a tincture of 5% iodine was applied to the 
umbilical cord of each calf, and calf birth weight was recorded. All calves were closely 
observed to ensure suckling of the dam and any calf not suckling within one hour of birth or 
showing signs of weakness was assisted to suckle the cow. After parturition, animals 
remained in the straw pens for a minimum of 4 days with the calf having free access to the 
dam. The calves had free access to their dams for suckling. Following parturition all cows 
received first cut grass silage ad libitum until turnout to pasture from the 20th March to the 
10th April, 2015. Meteorological conditions during the spring calving season (January to June 
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2015) recorded a mean ambient temperature of 7◦C (temp. range -2.7◦C to 20.6◦C), mean dry 
bulb temperature of 7.2◦C, and a mean wet bulb temperature of 5.9◦C.    
2.4 Cow vaccinations 
All cows were immunised against the inactivated antigen strain of BoHV-1 (gE-) with a 
primary vaccine (day -84) and a secondary vaccine (day -56) relative to the expected calving 
date (d 0), with 2 ml (S/C) of a commercial vaccine, Bovilis BoHV-1 (IBR) marker 
inactivated (MSD Animal Health, Buckinghamshire, UK). All cows received a combined 
rotavirus, coronavirus and E. coli F5 (K99) vaccine (inactivated) (Rotavec Corona) by intra-
muscular injection between 84 and 28 days prior to calving date. 
2.5 Calf vaccinations 
All calves were immunised at 14 days of age using 2 ml of a live commercial vaccine,  
Bovilis IBR marker (MSD Animal Health, Buckinghamshire, UK) delivered intra-nasally 
(I/N). Additionally, all calves were immunised with a primary vaccination of 
Bovilis®Bovipast RSP inactivated vaccine at 14 days of age and received a secondary 
(booster) vaccination at 42 days of age  using 2 ml subcutaneously (S/C) and 5 ml (S/C) of a 
commercial vaccine called Bovilis®Bovipast RSP, for the primary and booster vaccination, 
respectively (MSD Animal Health, Buckinghamshire, UK). Bovilis®Bovipast RSP vaccine 
has three components based on inactivated strains of serotype 1 and biotype A of 
M. haemolytica and two viruses, para-influenza -3 virus (PI-3V) and bovine respiratory 
syncytial virus (BRSV). 
2.6 Live weights and body composition 
Calf live weights were recorded at birth, and every 28 days thereafter throughout the study.. 
Cow live weights were recorded using calibrated scales, Tru-Test XR3000, load bars XHD 
10000, Auckland, New Zealand.   
2.7 Calf records and health 
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Calf sex, birthweight, and calving difficulty were recorded. Calves were weighed again at 
turnout to grass and every 28 days thereafter until cessation of blood sampling. Calves were 
categorised as healthy if they had no incidence of calf disease.  If a calf  presented with an 
elevated rectal temperature (>39.5oC), showed clinical signs of scour and or pneumonia using 
the Wisconsin Madison chart (McGuirk, 2008), it was considered unhealthy. A total of six 
calves were treated for navel illness, three calves were treated for scour (Cryptosporidium 
parvum), four calves were treated for pneumonia by day 7 post-birth, and one calf was treated 
for lameness and infection after disbudding, respectively. 
2.8 Colostrum / milk collection and sampling 
Three × 50 ml samples of colostrum/milk were collected at calving, prior to the initial feed (d 
0), and thereafter at d 2 and d 3 post-calving. Samples were collected from the left quarter of 
the dams’ udders. The udder was cleaned before sample collection to avoid any debris 
entering the sample. One × 50 ml colostrum samples (whole) was frozen at -20◦C for milk 
chemical analysis and submitted to the Newforge laboratory, Agri-Food and Biosciences 
Institute (AFBI), Hillsborough, Co. Down. Colostrum samples were analysed for total IgG. 
One × 50 ml colostrum samples were centrifuged at 2000 × g at 7◦C for 10 minutes. 
Following centrifugation, the fat-layer was removed with a sterile spatula. The supernatant 
(fat-free) was frozen at -20◦C for IgG analysis. 
2.9 Cow blood samples 
Cows (n = 30) were blood sampled by jugular venipuncture at d -84, d -56, d-28 pre-calving, 
at calving (d 0) and at d 14 post-calving. Two serum collection tubes (2 × 8.5 ml) (BD 
Vacutainer, Ireland: Serum Separator Tube II Advance Tubes) were collected on all sampling 
days. Blood samples were refrigerated for 24 hours at 4oC before sera were harvested by 
centrifugation (2000 × g at 4oC for 10 min). Sera were frozen at -20°C until assayed for 
specific antibody analysis (IBR gE- and BoHV-1 (wt)) and maternal passive transfer analysis. 
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2.10 Calf blood samples 
Blood samples were collected from calves (n=30) via jugular venipuncture into 2 × 8.5 ml 
BD Serum Separator Tube II Advance tubes (BD Vacutainer; Unitech, Ireland), and 1 × 6.0 
ml tube containing K3EDTA as anti-coagulant (Vacuette; Cruinn Diagnostics, Ireland). The 
blood samples were collected immediately at birth, prior to colostrum feeding (0 h), at 12 h, 
24 h, 72 h and 168 h after the initial feed of colostrum, and at d 7, 14, 28, 42, 56 and 84 post 
birth. Blood samples were refrigerated for 24 h before the sera were harvested by 
centrifugation at 4°C. Sera were frozen at -20 °C until assayed for specific antibody analysis 
(IBR gE-, BRSV, BoHV-1), and passive transfer analyses (serum ZST units and IgG 
concentrations).   
2.11 Colostrum and serum IgG analysis  
Colostrum (fat free) and serum (dam and calf) samples were thawed at 4oC overnight. IgG 
concentration was then determined using an enzyme-linked immunosorbent assay (ELISA) 
kit for bovine IgG from Bio-X Diagnostics (Jemelle, Belgium) (as described by Dunn et al. 
2017). All components of the kit were brought to room temperature (21◦C) before use. The 
wash buffer was diluted  20 fold with distilled water. A calibration curve was constructed and 
all samples were diluted at 1:225 in phosphate buffer saline (PBS), as per manufacturer’s 
instructions. All samples (100 µl) were added to the test plate and tested in duplicate, along 
with standards using a 96-well dilution plate. Equal volumes of horse radish peroxidase 
(HRP) conjugate was added to each well of the dilution plate and then 100 µl of this was 
transferred to the test plate. Each test plate was incubated at room temperature (21◦C) for 1 
hour. The plate was washed three times using wash solution. Chromogen solution 
(tetramethylbenzidine) was added to each well (100µl/well) and the plate was protected from 
light and incubated for 10 minutes at room temperature. Stop solution was added to each well 
(50 µl/well) and the absorbance (optical densities) of the samples was read at a wavelength of 
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450nm using a microplate spectrophotometer (Tecan Magellan, Männedorf, Switzerland). 
Negative controls were included on the test plate. An inter-assay CV of < 0.15 was observed. 
The mean absorbance at 450nm of each standard were plotted against known concentration to 
produce a standard curve. The mean absorbance at 450nm of samples was used to interpret 
the IgG concentration from the standard curve. The coefficient of determination value for 
each assay had to exceed 0.9 on the standard curve for inclusion within these results.  
2.12  Zinc sulphate turbidity (ZST) test 
Serum samples were analysed for ZST units, a control (100 µL of serum and 6 ml of distilled 
water) and test samples (100 µl of serum and 6 ml of zinc sulphate (0.208 g/l) were prepared 
and incubated at room temperature for 1 hour; samples were transferred into cuvettes and 
read using a spectrophotometer with a 520 nm filter, as described by McEwan et al. (1970). 
2.13 Haematology analysis 
Fresh whole K3EDTA blood samples (1 × 6 ml) (Vacuette; Cruinn Diagnostics, Ireland) were 
analysed within 1-2 h after collection using an ADVIA 2120 analyser (AV ADVIA 2120, 
Bayer Healthcare, Siemens, UK), which contained bovine software for haematological 
analysis of bovine blood. Red blood cell (RBC) number, differential white blood cell (WBC), 
neutrophil and platelet number were analysed.  
2.14 BoHV-1 (gE-) antibody 
Bovine herpesvirsus 1 (BoHV-1/BoHV1) gE- antibody was measured using an enzyme 
linked immunosorbent assay (ELISA) for BoHV-1 gE antibody from IDEXX (Hoofddrop, 
The Netherlands). The assay is performed using BoHV-1 antigen-coated microtitre plates.  
Test samples are applied to the plate and BoHV-1 antibodies, including gE-specific 
antibodies in the samples, bind to the viral antigen in the well. Following washing, an anti-
BoHV-1-gE specific monoclonal antibody conjugate is added to the microwells. The amount 
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of conjugate that reacts to the BoHV-1 gE antigen in the well is inversely proportional to the 
amount of gE specific antibody in the test sample. 
All kit reagents were brought to room temperature before use, by gently swirling and 
inverting reagents. The test protocol for antibody detection was followed according to the 
manufacturer’s instructions on 96 well plates, each well was coated with gE antigen. The 
optical densities (OD) of the samples were read at an absorbance of 650 nm using a micro 
plate spectrophotometer.  
The inter-assay CV was less than 15%. In the gE ELISA, values were expressed as a sample-
to-negative (S/N) ratio (samples were considered positive at an S/N ≤ 0.6).  
The S/N ratio of BoHV-1 (gE) antibody was calculated by dividing the absorbance of the 
sample by the mean absorbance of the negative control. If the S/N ratio was less than or equal 
to 0.6 then the sample is interpreted as BoHV-1 gE seropositive. An S/N ratio greater than or 
equal to 0.7 is interpreted as negative for the presence of circulating specific BoHV-1 gE 
antibodies. 
2.15 Infectious Bovine Rhinotracheitis (IBR) antibody determination 
BoHV-1 (Infectious Bovine Rhinotracheitis virus ((IBR-Ab)) wt and BRSV were analysed 
using indirect ELISA kits from (Svanova Biotech AB, Uppsala, Sweden). The test wells were  
coated with a mixture of viral and cellular proteins from virus-infected cells whereas control 
wells were coated with material from non-infected cells of identical type. All kit reagents 
were brought to room temperature before use, by gently swirling and inverting. The test 
protocol was followed according to manufacturer’s instructions. The optical density (OD) 
values were recorded using a microplate spectrophotometer with a 450 nm filter. The 
corrected OD value for controls and serum samples were calculated by subtracting the OD 
values of the corresponding wells containing the control antigen. The percentage positivity 
values were also calculated by dividing the corrected optical density (OD) value (ODcorr) of the 
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sample or negative control by the corrected OD value of the positive control and multiplying 
by 100.  
 
2.16 Bovine Respiratory Syncytial antibody (BRSV) determinations 
BRSV-specific antibodies were detected using a commercially available SVANOVIR® 
BRSV-Ab test kit. Indirect ELISA Samples were analysed in accordance with the 
manufacturer’s instructions. Briefly, serum samples (4µl) were added to wells coated with 
BRSV viral antigen and to corresponding wells coated with control antigen containing 100µl 
of sample dilution buffer. Milk samples were added directly to the wells (100µl/well). 
Positive and negative control sera were added. The plate was shaken thoroughly and 
incubated at 37oC for one hour. The plate was washed three times with PBS-Tween buffer, 
HRP conjugate was added to each well (100µl/well) and the plate was incubated for one hour 
at 37oC and then washed three times using PBS-Tween buffer. Substrate solution was added 
to each well (100µl/well) and the plate was protected from light and incubated for 10 minutes 
at room temperature. Stop solution was added (50µl/well) and the optical density of the 
samples and controls was read at a wavelength of 450nm using a microplate 
spectrophotometer (Tecan Magellan, Männedorf, Switzerland). Corrected OD (ODcorr) values 
for samples were calculated by substracting the optical density of the wells containing the 
control antigen from that of the corresponding wells coated in BRSV viral antigen. The mean 
ODcorr value for each of the controls was also calculated. The percentage positivity of each 
sample and negative control relative to the positive control was determined.   
3. Statistical analysis 
Data were checked for normality and homogeneity of variance by histograms, QQ-plots, and 
formal statistical tests as part of the UNIVARIATE procedure of SAS (version 9.3; SAS 
Institute, 2006). Data that were not normally distributed were transformed by raising the 
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variable to the power of lambda. The appropriate lambda value was obtained by conducting a 
Box-Cox transformation analysis using the TRANSREG procedure of SAS. The transformed 
data were used to calculate P-values. The corresponding least squares means (Lsmeans) and 
SEM of the non-transformed data are presented in the results for clarity. Haematological, 
physiological, serological data for both the dam and calf were analysed using repeated 
measures mixed model ANOVA (PROC MIXED, SAS v 9.3) with animal ID, breed (cow 
breed), sampling time and their interactions included as a fixed effect. REML linear mixed 
models, was performed to detect significant differences between experimental breeds. The 
statistical model consisted of the individual animal as the experimental unit in all analyses. 
Breed was the fixed effect within the model. Animal was included in each model as a random 
effect. For repeated measures, sampling time was included as the repeated measure. Non-
statistically significant interactions were removed from all the models. The type of variance-
covariance structure used was chosen depending on the magnitude of the Akaike information 
criterion (AIC) for models run under compound symmetry, unstructured, autoregressive, 
heterogeneous 1st order autoregressive, or Toeplitz variance-covariance structures. The 
model with the least AIC value was selected. The differences between mean values were 
determined by F-tests using Type III sums of squares. The PDIFF was applied as appropriate 
to evaluate pairwise comparisons between means. A probability of P < 0.05 was selected as 
the level of significance and statistically tendencies were reported when P < 0.10. Average 
daily gain (ADG) was determined by linear regression analysis. Differences between the 
means were examined using the PDIFF (difftype) option within the MIXED procedure of 
SAS. Means were considered statistically significant at a probability level of P < 0.05.  
4. Results 
4.1 Cow live weight and body composition changes  
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The mean (SD) live weight at calving was greater (P<0.01) for CL cows (765 (71.7) kg) than 
for LF (677 (65.8) kg). There was no difference in calf birth weight, vigour or calving 
difficulty score between genotypes (Table 1). Cow docility score was greater (P < 0.001) for 
CL compared to LF cows (Table 1). The mean (SD) BCS for CL and LF cows at calving was 
3.0 (0.15) and 2.6 (0.14), respectively.   
 
4.2  Calf performance 
Mean (SD) calf birth weight was similar (P>0.05) for the progeny of CL (46.4 (4.74) kg) and 
LF (46.6 (6.27) kg) cows. The live weight gain of calves from LF cows was greater from 
birth to weaning (P<0.05) compared to the calves from CL cows. Male calves from LF cows 
had greater ADG (P<0.05) compared to male progeny from CL cows (Table 1), with no 
difference among female calves.   
4.3 Colostrum IgG profile 
There was no effect (P>0.05) of parity on colostrum or milk IgG concentrations. There were 
no significant breed × time interactions, or breed effect (P>0.05) observed for dam colostrum 
and transitional milk total IgG concentration. However, time had a significant effect (P ≤ 
0.05) on colostrum and milk IgG concentrations (Fig 1). Total IgG concentrations decreased 
at d 2 and d 3 for CL cows, whereas IgG concentrations decreased at d 3 for LF cows, 
relative to calving (d 0). 
4.4 Cow serum IgG concentrations 
Cow serum IgG concentrations pre and post-partum are presented in Table 3 and the effects 
of breed, time and time by breed interaction both pre and post-partum are summarised. There 
was no effect (P>0.05) of parity on cow serum IgG concentrations. There was a significant 
breed × time interaction (P ≤ 0.05) and time effect (P < 0.05) for serum IgG concentrations in 
CL and LF cows. Pre-calving at d -84, LF cows had greater (P<0.05) serum IgG 
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concentrations than CL cows (Table 2). LF and CL cow serum IgG concentrations decreased 
significantly at calving compared to d -84.  At calving, serum IgG concentration had 
decreased (P<0.05) for both genotypes. Post-partum, serum IgG concentrations increased 
(P<0.05) in LF cows at d 14 with no change (P>0.05) in CL cows.  
4.5 Calf immunological profiles  
Calf serum was analysed for passive transfer immunological variables (Fig. 2). There were no 
breed × time interactions, or breed effect (P ≥ 0.05) observed for serum ZST units and IgG 
concentration. However, an effect of time (P ≤ 0.05) was observed for serum ZST units and 
IgG concentration (Fig. 2).  
4.6 Vaccine response of the dam 
There was no effect (P>0.05) of parity on vaccine antibody responses. There was no 
significant breed × time interaction (P> 0.05), breed effect (P > 0.05) or time (P>0.05) 
observed for dam vaccine antibody responses for IBR gE-, IBR S/N ratio and BoHV-1 (wt). 
(Table 3).   
4.7 Vaccine responses of the calves 
There was no breed × time interaction (P> 0.05), or breed effect (P>0.05) observed in calves 
for maternal antibody levels for BRSV %, BoHV-1 gE- S/N ratio, or BoHV-1 % (wt) (total 
antibody) values (Table 4). Time had a significant effect (P < 0.05) on maternal antibody 
responses. The BRSV%, BRSV S/N ratio, and BoHV-1 % (wt) responses increased (P<0.05) 
at all time-points for the progeny of CL and LF cows. The IBR gE S/N ratios decreased at all 
time-points, relative to d 0 for the progeny of LF cows, whereas antibody titre levels 
decreased at 12 h, 24 h, 48 h, 72 h, and d 7, for the  progeny of CL cows (Table 4). There was 
no increase in antibody responses in sera of calves to the agent circulating in the vaccines that 
were administered at d 14 and at d 42.  
 4.8 Calf haematological profiles 
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There were no breed × time interactions, or breed effect (P ≥ 0.05) observed for any of the 
haematological profiles. However, time had a significant effect (P ≤ 0.0001) on calf 
haematological profiles (Table 5). There was no difference in RBC, platelet or neutrophil 
number at birth for the progeny of CL and LF cows. However, the progeny of LF dams had 
greater WBC number compared to the progeny of CL. Neutrophil number decreased (P<0.05) 
at 72 h, d 7, d 28, d 42 in the progeny of CL cows. Likewise, a decrease in neutrophil number 
was observed across all time-points for the progeny of LF cows, relative to d 0. Red blood 
cell number decreased at all time-points up to d 14, and increased at d 56 and d 84, in the 
progeny of CL cows. A similar decrease was observed for red blood cell number in the 
progeny of LF cows (up to d 14) and numbers increased (P<0.05) thereafter at d 28, d 42, d 
56 and d 84. Platelet numbers increased at d 14, d 28, d 42, d 56, d 84 for both progeny of CL 
and LF cows. White blood cell number decreased (P<0.05) at all time-points in the progeny 
of LF cows, whereas numbers decreased (P<0.05) at 48 h, 72 h and d7 in the progeny of CL 
cows (Table 7).   
5. Discussion 
Our study objectives were to characterise the development of immunocompetence in beef 
suckler calves from birth to three months of age, and to trace glycoprotein E (gE)-negative 
BoHV-1 antibodies from vaccinated dams to calf sera and investigate how passive transfer 
affects response to live BoHV-1 vaccine at 14 days of age, and to Bovilis®Bovipast RSP 
vaccine at 14 and 42 days of age.  
Our results show a greater decrease in cow serum IgG concentration in LF cows than CL 
cows suggesting that more Ig was transferred into the mammary secretion. There was a 
subsequent increase in beef cow serum IgG concentrations in LF but not for CL cows, post-
partum.  McGee et al. (2005a; 2006) reported that Charolais cows did not transfer 
immunoglobulin subclass IgG1 as efficiently in their bloodstream as beef × Friesian cows and 
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that Charolais cows produce lower IgG1 mass. Similarly, Murphy et al. (2005) reported a 
greater decrease in serum IgG1 concentrations in cows between 90 days pre partum and 
parturition for LF cows.  
In the present study, the progeny of LF cows had a greater pre-weaning average daily gain 
than the progeny of CL cows. In agreement with these findings, McGee (2005b) and Murphy 
et al. (2008) reported similar pre-weaning live weight gain for the progeny of beef × Friesian 
cows, compared to the progeny of Charolais cows. This finding of greater ADG from the 
progeny of LF cows may be associated with a greater milk yield in LF cows compared to 
purebred continental cow genotypes, such as CL.  Furthermore, other studies reported that the 
progeny of Limousin and Charolais cows have lower pre-weaning weights than SLF cows 
(Fredeen et al., 1982b; Gregory et al., 1992). This finding concurs with previous studies 
comparing beef cow genotypes and dairy × beef cow genotypes (Wright et al., 1994; McGee 
et al., 2005b).  
In our study, calf haematological profiles were consistent with the reference range reported 
(Egli and Bloom, 1998; Knowles et al., 2000; Kramer, 2000).  Mean white blood cell number 
was greater at birth in the progeny of LF cows, however, numbers subsequently decreased 
and were within the reference range at the other sampling times (Knowles et al., 2000; 
Zanker et al., 2001a). Neutrophil number was greater than reference values at the 24 h 
sampling time and then reached normal reference values on subsequent sampling days. It is 
probable that the increased WBC and neutrophil number (neutrophilia) within 24 h of birth 
may be attributed to greater cortisol concentration in circulation. Neutrophilia and reductions 
in the number of monocytes, eosinophils and basophils in circulation have been associated 
with the stress response to raised cortisol in circulation in bovine animals (Burton et al., 
2005; Lynch et al., 2012; O’Loughlin et al., 2014). Moreover, Chase et al. (2008) reported 
that calves produce high levels of cortisol at parturition and serum cortisol concentrations 
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remain increased throughout the first week post birth. The number of B cells is greatly 
reduced in the neonate at 4% of the total lymphocytes at a week of age and increase gradually 
to 20% of total lymphocytes at 6-8 weeks of age. This low number of B cells coupled with 
the TH2 environment induced by the calves endogenous corticosteroids, maternal and 
placenta hormones results in a lack of an antibody response until at least three weeks of age.  
In the present study, platelet number was not different across sampling times, whereas 
Knowles et al. (2000) and Egli and Blum (1998) reported that the platelet number was within 
reference range at birth, with an increasing trend, that after six days values reached the adult 
reference range.  
In Ireland, limited information has emerged regarding bovine herpesvirus 1 (BoHV-1) 
infection, albeit from a subset of Irish beef herds (O’Grady et al., 2008) of which 73.2% were 
seropositive. BoHV-1 virus causes respiratory infections and abortions in cattle, and is an 
important component of the bovine respiratory disease complex, which causes a considerable 
economic loss worldwide (Chowdhury et al., 2016). Pre-partum vaccination programs have 
been reported to increase colostral antibodies and protect newborn calves from viruses 
associated with calf pneumonia, for example, Mannheimia haemolytica, BRSV, and PI3V 
(Makoschey et al., 2012; Dudek et al., 2014). M. haemolytica is a primary bacterial pathogen 
associated with BRD (Reddy et al., 2012). Thus, specific pre-partum immunisation of cows 
provides a significant increase in specific antibody protection against infectious disease via 
colostrum intake, and effectively stimulates a natural immune response in their offspring 
(Crouch et al., 2001). Vaccination of the young calf is often practiced in an effort to provide 
additional protection from common disease causing pathogens during the first few months of 
life, as the immune system matures and maternal antibodies decay (Chase et al., 2008).  
In the present study, CL and LF cows tested negative to the gE antigen of BoHV-1 during the 
dry period  (S/N = > 0.70). Similarly reports from Van Oirschot et al. (1997) demonstrated 
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that sera from cattle that were vaccinated with a gE- negative marker vaccine scored 
negative. Van Oirschot et al. (1997) reported that cattle naturally exposed to BoHV-1 tested 
positive for antibodies to the gE antigen of BoHV-1 in the gE- ELISA. In addition to this, 
animals that received an initial vaccination and were then challenged with infection, thus 
having reduced virus replication, also became gE-seropositive.  
As a result of vaccinating the dam with a marker vaccine in this current study, the antibodies 
were then traceable in the calf sera post colostrum intake and calves also scored negative to 
the gE antibody. This demonstrated the transfer of the BoHV-1 specific antibodies from 
vaccination to the calves and consequently it could be verified that this came from the marker 
vaccine administered to the dam as the calves were also gE negative when tested by ELISA.  
All calves in the present study had elevated maternally derived antibodies to BRSV and 
BoHV-1 (wt) by 12 hours post-birth. Cowley et al. (2009)  reported herd-level seroprevalence 
of BoHV-1 in Ireland at a rate of 74.9%, which is in agreement with previous findings for 
bulls (O’Grady et al 2008), and with the results of the present study.  Our findings showed 
that the cows had total BoHV-1 (wt) antibodies circulating in their blood; this indicated that 
these animals had been naturally exposed to BoHV-1 at some stage in their lifetime. 
Consequently we found calves to have a considerable level of BoHV-1 (wt) as well as BRSV 
antibodies circulating in their blood post colostral consumption as a result of MDAs. This 
finding supports a study that was carried out in Ireland during 2009 to estimate dairy and beef 
herd seroprevalence of BoHV-1; findings showed a high seroprevalence of 74.9% (95% C.I. 
69.9 to 79.8%), where only 2% of herds within the study vaccinated the dams, which 
indicates that infection in widespread (Cowley et al., 2011). This is similar to reports from 
the UK where 83.2% of unvaccinated herds had a minimum of one BoHV-1 seropositive 
animal, and the mean cattle and herd sero-prevalence of BoHV-1 was 42.5% and 43.1%, 
respectively (Woodbine et al., 2009).   
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A study by Munoz-Zanzi et al. (2002) reported that the duration of passively transferred 
immunity to respiratory diseases was associated with the concentration of antibodies during 
the first 3 days of life. Therefore the greater the antibody concentration, the longer time it 
takes for MDAs to decay. This may be due to the high quality and timely manner in which 
calves suckled their dams post-birth. It is likely therefore that at 14 days post birth not all of 
these MDAs have decayed. Furthermore, Chamorro et al. (2014) reported that calves with 
adequate IgG concentration can have highly variable responses to specific respiratory viruses 
such as BRSV and BoHV-1. It has been suggested that this may be due to the differences in 
maternal colostrum sources, dam vaccination history,  natural exposure to infection and levels 
of specific viral antibodies in the colostrum.  
At the time of the primary BRSV vaccination of the calves at 14 days of age we observed that 
there was no increase in antibody levels to the agent circulating in the vaccine in the calves’ 
blood. This may be due to the presence and interference of maternal antibody from colostrum 
and the immaturity of the immune system at this young age (Tyler et al., 1989). Although 
post primary or secondary vaccination did not result in an increase in antibody levels in the 
blood, it is likely that a cell mediated response may have occurred post vaccination (Fulton et 
al., 2004). BRSV is a challenging issue in calves; maternal antibodies are often present in 1 
to 6 month old calves, this can have a knock on effect on vaccination programs because these 
antibodies do not decay until approximately 40 days of age (van der Poel et al., 1999; Chase 
et al., 2008). Our results are similar with no response to vaccination.  
Reports from Lemaire et al. (2001) showed the ability of a BoHV-1 gE-negative vaccine 
strain to establish latency in both seronegative and calves that received passive immunity 
subsequent to a single intranasal immunization. However the efficacy of the gE negative 
vaccine was reduced in calves which received maternal antibodies. Passively acquired 
antibodies to BRD viruses affect the development of active immunity to these viruses in 
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calves. The presence of potentially ‘inhibitory’ maternally derived antibodies, in combination 
with the bias of the immature neonatal immune system towards Th2 responsiveness, are clear 
obstacles to the effectiveness of vaccines delivered in the neonatal period (Morein et al., 
2002).  
In conclusion, the mean level of antibodies to the gE antigen of BoHV-1 during the dry 
period were negative due to the presence of artificial infection via marker vaccine. The 
results demonstrated that repeated vaccination of the dams with the gE marker vaccine 
produced a gE negative colostrum with very high levels of BoHV-1 antibody and that calves 
efficiently consumed the colostrum to acquire adequate transfer of passive immunity. As 
expected the maternally derived antibody titres for the specific respiratory viruses were at 
their peak levels post colostrum ingestion. Antibodies to the gE antigen of BoHV-1 tested 
negative within both treatment groups as a result of pre-parturient immunisation. There were 
no differences between the progeny of CL and LF cows in the level of BRSV antibodies post 
vaccination at 2 weeks of age and post booster vaccination 4 weeks later. Further research 
relating to BRD complex infections and the processes involved in the acquisition of 
immunity via vaccination are required to both improve the effectiveness of current 
preventative immunisation strategies and to aid development of new and more effective 
vaccines that could be used in the presence of MDAs.  
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Table 1: Cow and calf live weight, characteristics of cows at calving (d 0), and calf 
performance. The vales are expressed as mean (SEM). 
  Cow genotype   
 
Charolais × 
Limousin (CL) 
Limousin × 
Friesian (LF) Significance 
Cow live weight at d 0 765 (71.7) 677 (65.8) P<0.01 
Calf birth weight 46.4 (4.74) 46.6 (6.27) ns 
1 Calf vigour 4 (0.82) 3.76 (0.66) ns 
2 Calving difficulty score 1 (0) 1.29 (0.59) ns 
3 Cow docility 3.4 (1.26) 2.1 (0.66) P<0.001 
Calf average daily gain 
(ADG) from birth to weaning 1.12 (0.14) 1.3 (0.16) P<0.01 
Male calf ADG from birth to 
weaning 1.16 (0.13) 1.4 (0.13) P<0.01 
Female calf ADG from birth 
to weaning 1.08 (0.15) 1.15 (0.07) ns 
 
1Calf vigour [1= normal, vigorous calf; 2= weak calf that sucked without assistance; 3= weak 
calf needed assistance to suck];  2Calving difficulty score (0 to 5 scale), [1 = no assistance; 2 
= slight assistance; 3 = moderate mechanical assistance (calving jack needed); 4 = ‘hard’ 
mechanical assistance / veterinary assistance, 5 = caesarean]; 3Cow docility score after 
calving (1 to 6 scale) with 1 being very docile to 6 being very aggressive); ns =  not 
significant. 
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Table 2: Least square means (SEM) for the effect of cow breed on dam serum IgG concentration, at d-84, d-56, d-28, calving (d 0) and d 14, 
relative to calving 
Variable 
Cow 
genotype 
Time in days (d) Significance 
 
 d-84 d-56 d-28 d 0 d 14 
 
Breed 
 
Day 
 
Breed × Day 
Dam serum IgG 
CL 
 
18.3 
(1.46) 
19.0 
 (1.46) 
18.5 
 (1.46) 
20.8 a 
 (1.46) 
20.5 
 (1.46) 0.26 0.01 
 
 
 
<0.0001 
(mg/ml) 
 
LF 
 
23.8b 
(1.46) 
22.4 
(1.46) 
21.3a 
(1.46) 
17.4a 
(1.46) 
22.91b 
(1.48)  
 
 
Cow genotype CL = Charolais × Limousin (n=13); LF = Limousin × Friesian (n=17); a Within rows, Lsmeans differ from d 0 by P <  0.05; 
bLsmeans differ between CL and LF at d-84;  
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Table 3: Least square means (SEM) for antibody response to vaccination in cows at d-84, d-56, d-28, calving (d 0) and d 14, relative to calving 
Variable 
Cow 
genotype Time in days (d) Significance 
  d -84 d -56 d -28 d 0 d 14 Breed Day Breed × Day 
 
BoHV-1  
gE S/N 
Ratio 
CL 
 
0.85 
(0.09) 
0.86 
(0.09) 
0.89 
(0.09) 
0.85 
(0.09) 
0.86 
(0.09) 0.25 0.71 0.94 
LF 
 
0.73 
(0.08) 
0.72 
(0.08) 
0.77 
(0.08) 
0.73 
(0.08) 
0.70 
(0.08) 
   
Total 
antibody 
to BoHV-1 
(wt) 
 
CL 
 
1.17 
(0.05) 
1.24 
(0.05) 
1.21 
(0.05) 
1.15 
(0.05) 
1.13 
(0.05) 0.87 0.09 0.61 
LF 
 
 
1.12 
(0.04) 
 
1.18 
(0.04) 
 
1.21 
(0.04) 
 
1.19 
(0.04) 
 
1.13a 
(0.04) 
  
  Cow genotype CL = Charolais × Limousin (n=13); LF = Limousin × Friesian (n=17); aWithin rows, Lsmeans differ from d 0 by P < 0.05.  
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Table 4: Least square means (SEM) for maternally derived antibodies, and responses to vaccination in calves.  
Variab
le 
Cow 
genotype Time in days (d)  Significance 
 
 0 h 
12 
h 
24 
h 48 h 72 h d 7 d 14 d 28 d 42 d 56 d 84 Breed Time 
Breed × 
Time 
BRSV 
(%) 
 
CL 
 
1.4
6 
(5.80) 
55.
4
4
a 
(6.02) 
70.
3
4
  
(5.45) 
82.4
3
a 
(5.45) 
87.0
3
a 
(5.45) 
88.8
5
a 
(5.45) 
88.7
7
a 
(5.45) 
84.0
4
a 
(5.45) 
76.3
1
 
a 
(5.80) 
84.5
9
a 
(5.61) 
66.7
2
a 
(5.45) 
0.2
7 
<0.00
0
1 0.90 
 
LF 
 
2.7
6 
(5.93) 
58.
3
1
  
(5.20) 
83.
7
0
  
(5.07) 
90.7
5
  
(5.07) 
92.1
1
a 
(5.07) 
93.1
0
a 
(5.07) 
95.3
9
a 
(5.07) 
89.2
1
a 
(5.07) 
82.5
9
 
a 
(5.20) 
83.3
0
a 
(5.07) 
67.3
9
a 
(5.07)    
 
BoHV
-1 
gE 
S/N 
Ratio 
 
CL 
 
0.9
7 
(0.10) 
 
0.8
3
 
a 
(0.10) 
 
0.8
3
 
a 
(0.09) 
 
0.84
a 
(0.09) 
 
0.85 
a 
(0.09) 
 
0.85 
a 
(0.09) 
 
0.97 
(0.09) 
 
0.88 
(0.09) 
 
0.89 
(0.10) 
 
0.87 
(0.10) 
 
0.89 
(0.09) 
 
0.1
1 
0.000
6 0.43 
 
LF 
 
 
 
0.8
9 
(0.09) 
 
 
0.6
3
 
a 
(0.09) 
 
 
0.6
5
 
a 
(0.09) 
 
 
0.68
a 
(0.09) 
 
 
0.65 
a 
(0.09) 
 
 
0.65 
a 
(0.09) 
 
 
0.61 
a 
(0.09) 
 
 
0.66 
a 
(0.09) 
 
 
0.68 
a 
(0.09) 
 
 
0.64 
a 
(0.09) 
 
 
0.73 
a 
(0.09) 
 
    
Total 
antibo
dy to 
BoHV
-1 
(wt) 
CL 
 
 
 
0.1
6
  
(0.0
8
) 
 
 
1.0
9
 
a 
(0.09) 
 
 
1.0
5
 
a 
(0.08) 
 
 
1.00
a 
(0.08) 
 
 
1.00 
a 
(0.08) 
 
 
0.97 
a 
(0.08) 
 
 
1.05 
a 
(0.08) 
 
 
1.07 
a 
(0.08) 
 
 
1.02 
a 
(0.08) 
 
 
1.04 
a 
(0.08) 
 
 
0.91 
a 
(0.08) 
 
 
0.4
6 
<0.00
0
1 0.89 
 
LF 
 
 
0.2
1 
(0.08) 
1.1
5
 
1.2
0
 
1.17 
a 
(0.07) 
1.05 
a 
(0.07) 
1.09 
a 
(0.07) 
1.01 
a 
(0.07) 
1.11 
a 
(0.07) 
1.00 
a 
(0.07) 
1.05 
a 
(0.07) 
0.95 
a 
(0.07)    
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 a 
(0.07) 
 
a 
(0.07) 
 
        
Cow genotype; CL = Charolais × Limousin (n=13); LF= Limousin × Friesian (n=15); 
a 
=Within rows, Lsmeans differ from d 0 by P < 0.05. 
Wild type = (wt) 
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Table 5:  Least square means (SEM) for neutrophil, red blood cell, platelet and white blood cell numbers from birth (d 0) to d 84 for the progeny of CL and 
LF cows 
Variable 
Cow 
genotype 
Time in days (d)  
 
Bree
d 
 
Time 
 
Breed × 
Time 
 
 
0 h 
 
24 h 
 
48 h 
 
72 h 
 
d 7 
 
d 14 
 
d 28 
 
d 42 
 
d 56 
 
d 84 
 
0.23 
<0.000
1 
 
 
 
0.11 
 
 
 
Neutrophil
s 
(×10
3
 
cells/µl) 
CL 
 
5.4 
(0.73) 
6.5 
(0.85) 
4.1 
(0.48) 
3.7 
a
 
(0.45) 
3.4
 a
 
(0.41) 
4.9 
(0.71) 
3.4 
a
 
(0.49) 
3.2 
a
 
(0.76) 
4.2 
(0.40) 
2.6
  a
 
(0.45) 
LF 6.2 
(0.69) 
7.2 
a
 
(0.76) 
5.0 
a
 
(0.43) 
4.0 
a
 
(0.40) 
3.8 
a
 
(0.37) 
4.4 
a
 
(0.64) 
4.2 
a
 
(0.45) 
4.4 
a
 
(0.69) 
3.3 
a
 
(0.37) 
3.4 
a
 
(0.42) 
 
RBC 
(×10
6
 cells/ 
μl) 
 
CL 
 
9.8 
(0.34) 
8.1 
a
 
(0.32) 
8.1 
a
 
(0.32) 
8.0 
a
 
(0.32) 
7.9 
a
 
(0.32) 
8.5 
a
 
(0.32) 
9.4 
(0.32) 
10.2 
(0.33) 
11.2 
a
 
(0.32) 
13.1
 a
 
(0.32) 
0.26 
<0.000
1 
0.14 
LF 
 
9.1 
(0.34) 
8.3 
a
 
(0.29) 
7.9 
a
 
(0.29) 
7.6 
a
 
(0.29) 
7.7 
a
 
(0.29) 
8.7 
a
 
(0.29) 
9.3 
(0.30) 
9.7 
(0.30) 
10.5 
(0.30) 
11.8 
(0.30) 
 
Platelets 
(×10
3
 
cells/µl) 
 
CL 
 
623.9 
(52.67
) 
 
468.2 
a
 
(39.80
) 
 
498.2 
(46.91
) 
 
550.9 
(58.87
) 
 
966.5 
a
 
(75.75
) 
 
963.8 
a
 
(57.00
) 
 
815.6 
a
 
(55.26
) 
 
825.6 
a
 
(59.58
) 
 
806.3 
a
 
(65.06
) 
 
703.9 
a
 
(59.88) 
0.06 
<0.000
1 
0.69 
LF 
 
 
539.2 
(51.95
) 
445.9 
(35.88
) 
465.3 
(42.28
) 
445.3 
(53.06
) 
895.0 
a
 
(68.28
) 
768.6 
a
 
(51.38
) 
815.4 
a
 
(50.98
) 
692.9 
a
 
(53.78
) 
740.6 
a
 
(60.23
) 
631.6 
a
 
(55.23) 
WBC 
(×10
3
 
cells/µl) 
CL 
 
12.3 
(1.44) 
11.4 
(1.34) 
7.7 
a
 
(1.34) 
7.7
  a
 
(1.34) 
8.3 
a
 
(1.34) 
10.8 
(1.34) 
9.5 
(1.34) 
10.0 
(1.38) 
11.9 
(1.34) 
11.4 
(1.34) 
0.46 
<0.000
1 
0.08 
LF 
 
20.3
b
 
(1.49) 
11.3
 a
 
(1.21) 
8.0 
a
 
(1.21) 
7.3
 a
 
(1.21) 
8.6 
a
 
(1.21) 
10.2 
a
 
(1.21) 
10.6 
a
 
(1.24) 
10.9 
a
 
(1.24) 
10.6 
a
 
(1.25) 
12.0 
a
 
(1.25) 
Cow genotype CL = Charolais × Limousin (n=13); LF = Limousin × Friesian (n=17); RBC = red blood cells; WBC = white blood cell. The values are 
expressed as least square means (Lsmeans) and SEM;
 a
 Within rows, Lsmeans differ from d 0 by P <  0.05.  
b 
Within column different from CL progeny. 
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Figure legends 
 
Fig 1. The effect of cow breed on colostrum and transitional milks IgG concentrations, at calving (d 0) and at day 2 and 3 relative to calving. 
Cow genotype CL = Charolais × Limousin (n=13); LF = Limousin × Friesian (n=17); Fig 2.  Least square means (SEM) for serum Zinc Sulphate 
turbidity (ZST) Units and IgG concentration, from birth (0 h) to d 7 for the progeny of CL and LF cows  
 
Fig 2.  Least square means (SEM) for serum Zinc Sulphate turbidity (ZST) Units and IgG concentration, from birth (0 h) to d 7 for the progeny 
of CL and LF cows  
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Figure 1  
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Figure 2  
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Highlights 
 Greater decrease in cow serum IgG concentration in LF cows than CL cows pre-partum;  
 Progeny of LF cows have a greater pre-weaning ADG than the progeny of CL cows; 
 Maternally derived antibodies affects response to vaccination in suckled beef calves; 
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